Clinical Application of Anlotinib Combined with Docetaxel: Safe and Effective Treatment for Lung Carcinoma

OBJECTIVE: To compare the clinical efficacy and long-term survival between anlotinib monotherapy and anlotinib plus docetaxel in patients with lung carcinoma. METHODS: Between October 2019 and December 2021, 84 patients with lung cancer diagnosed and treated at our hospital were enrolled and randoml...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Xiang, Jing, Xin, Liu, Yongshi, Huang, Jiangbo, Yang, Sanhu, Yun, Yuhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586802/
https://www.ncbi.nlm.nih.gov/pubmed/36277984
http://dx.doi.org/10.1155/2022/2483816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586802/
https://www.ncbi.nlm.nih.gov/pubmed/36277984
http://dx.doi.org/10.1155/2022/2483816

Ejemplares similares